Rosiglitazone lowers resting and blood pressure response to exercise in men with type 2 diabetes: A 1-year randomized study.

Marie-Eve PichéAnne-Sophie LabergePatrice BrassardBenoit J ArsenaultOlivier F BertrandJean-Pierre DesprésOlivier CosteroussePaul Poirier

Published in: Diabetes, obesity & metabolism (2018)

The insulin sensitizer rosiglitazone has a beneficial effect on resting and BP response to exercise in men with CAD and T2D, especially in those with an exaggerated BP response to exercise.

Keyphrases

high intensity
heart rate
blood pressure
physical activity
resistance training
heart rate variability
type diabetes
coronary artery disease
middle aged
body composition
hypertensive patients
insulin resistance